STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
225.82
+0.64 (0.28%)
Nov 4, 2024, 4:00 PM EST - Market closed

STERIS Revenue

STERIS had revenue of $1.28B in the quarter ending June 30, 2024, with 8.12% growth. This brings the company's revenue in the last twelve months to $5.23B, up 14.72% year-over-year. In the fiscal year ending March 31, 2024, STERIS had annual revenue of $5.14B with 13.28% growth.

Revenue (ttm)
$5.23B
Revenue Growth
+14.72%
P/S Ratio
4.25
Revenue / Employee
$287,960
Employees
18,179
Market Cap
22.27B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20245.14B602.44M13.28%
Mar 31, 20234.54B312.86M7.41%
Mar 31, 20224.22B1.12B35.91%
Mar 31, 20213.11B76.62M2.53%
Mar 31, 20203.03B248.73M8.94%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Koninklijke Philips 20.12B
Teva Pharmaceutical 16.29B
Biogen 9.61B
Zimmer Biomet Holdings 7.60B
Moderna 5.05B
Illumina 4.43B
The Cooper Companies 3.80B
BeiGene 3.10B
Revenue Rankings